Jörg is currently working for the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, as regulatory-scientific expert and assessor (pharmaceutical quality and non-clinic) for antibody based therapeutics, as well as for biomarkers and companion diagnostics as part of personalized medicines. He is involved in the European process of authorization of biopharmaceuticals, comprising scientific assessments and advices. Further activities are assessments of GCP conformity of clinical phase I-III trials and both national and third-country (USA / Asia) GMP inspections. s. For EDQM he is acting as expert in the Host-Cell Protein Working Party and in the P4Bio (Biosimilar) Working Party and for EMA he is acting as member in the Pharmacogenomics Working Party and in the new Companion Diagnostic Consultation Working Group. He has been also co-author of the EMA guideline on production and quality control of monoclonal antibodies and related substances. Jörg holds a Diploma in biology and a PhD (cell biology). Before he joined the PEI, Jörg has gained large experience in experimental cancer and neuropharmacology research with focus on targeted monoclonal antibody and biomarker based personalized biomedicines. In this time he was head of “Neuropharmacology laboratory” and in parallel head of clinical core “Genotyping service center” at Department of Neurology at University of Essen Medical School. Before, he has been scientific project leader in various cancer research projects and in parallel head of the core “Monoclonal antibody research and production unit” at the Institute of Cell Biology at the West German Cancer Center.
Events/Masterclasses Dr. Jörg Engelbergs is currently speaking at
Pharma
Stability & Shelf Life of Biologics
Online Live Stream
The purpose of this Stability & Shelf Life of Biologics Training Course is to get comprehensive overview on stability and shelf-life regulatory landscape.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Jörg is currently working for the Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, as regulatory-scientific expert and assessor (pharmaceutical quality and non-clinic) for antibody based therapeutics, as well as for biomarkers and companion diagnostics as part of personalized medicines. He is involved in the European process of authorization of biopharmaceuticals, comprising scientific assessments and advices. Further activities are assessments of GCP conformity of clinical phase I-III trials and both national and third-country (USA / Asia) GMP inspections. s. For EDQM he is acting as expert in the Host-Cell Protein Working Party and in the P4Bio (Biosimilar) Working Party and for EMA he is acting as member in the Pharmacogenomics Working Party and in the new Companion Diagnostic Consultation Working Group. He has been also co-author of the EMA guideline on production and quality control of monoclonal antibodies and related substances. Jörg holds a Diploma in biology and a PhD (cell biology). Before he joined the PEI, Jörg has gained large experience in experimental cancer and neuropharmacology research with focus on targeted monoclonal antibody and biomarker based personalized biomedicines. In this time he was head of "Neuropharmacology laboratory" and in parallel head of clinical core “Genotyping service center" at Department of Neurology at University of Essen Medical School. Before, he has been scientific project leader in various cancer research projects and in parallel head of the core "Monoclonal antibody research and production unit" at the Institute of Cell Biology at the West German Cancer Center.
